tradingkey.logo
tradingkey.logo
Search

Palvella Therapeutics Inc

PVLA
Add to Watchlist
153.080USD
-1.240-0.80%
Market hours 09/18, 12:53ET
2.20BMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

-0.80%

5 Days

+1.79%

1 Month

-0.29%

6 Months

+26.72%

Year to Date

+46.25%

1 Year

+170.60%

Key Figures

155.090Open
153.900High
1.72KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.01%Turnover Ratio
154.320Prev. Close
151.960Low
262.45KTurnover
LossP/E Static
10.16P/B
0.00%Div Yield TTM
-28.73%ROA
161.38052wk High
0.02Volume Ratio
-17.43MNet Profit
14.40MShares
-4.1694EPS TTM
-0.14Beta
-34.25%ROE
56.22052wk Low
1.26%Amplitude
100.00%Gross Margin
2.20BMarket Cap
5.61Reward/Risk
5.25%Risk Rate
Recent
Earnings
More news coming soon, stay tuned...

Palvella Therapeutics Inc's Score

0.06vs previous score
Forecast8.50
Financial Health6.80
Technical3.95
Valuation Dimensions9.53
Institutional Confidence7.00
Risk Assessment5.20

Media Coverage

Coverage Level

Very Low
Very High
Neutral

Analyst Rating

Strong Buy
Buy
Hold
Sell
Strong Sell
BuyCurrent Rating
229.875Target Price
+52.01%Upside Space
Current Rating2026-092026-082026-072026-062026-052026-042026-032026-02
Strong Buy44454444
Buy1212121212121212
Hold00000000
Sell00000000
Strong Sell00000000

Palvella Therapeutics Inc Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D

Technical Indicators

Sell

Summary

Buy

Moving Average

Strong buy

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-1.52/-1.16
Revenue / Forecast
--/0.00

Palvella Therapeutics Inc Profile

SectorBiotechnology & Medical Research
Ticker SymbolPVLA
Number of employees14
CountryUnited States of America

Ownership

ShareholdersProportion
Suvretta Capital Management, LLC6.22%
BVF Partners L.P.6.13%
Kaupinen (Wesley H.)5.76%
Frazier Life Sciences Management, L.P.5.04%
Shareholder TypesProportion
Investment Advisor/Hedge Fund25.54%
Investment Advisor23.56%
Hedge Fund20.39%
Individual Investor11.65%

FAQs

What is the current price of Palvella Therapeutics Inc (PVLA)?

The current price of Palvella Therapeutics Inc (PVLA) is 154.32.

What is the symbol of Palvella Therapeutics Inc?

The ticker symbol of Palvella Therapeutics Inc is PVLA.

What is the 52-week high of Palvella Therapeutics Inc?

The 52-week high of Palvella Therapeutics Inc is 161.38.

What is the 52-week low of Palvella Therapeutics Inc?

The 52-week low of Palvella Therapeutics Inc is 56.22.

What is the market capitalization of Palvella Therapeutics Inc?

The market capitalization of Palvella Therapeutics Inc is 2.21B.

Is Palvella Therapeutics Inc (PVLA) currently rated as Buy, Hold, or Sell?

According to analysts, Palvella Therapeutics Inc (PVLA) has an overall rating of Buy, with a price target of 229.88.

What is the Earnings Per Share (EPS TTM) of Palvella Therapeutics Inc (PVLA)?

The Earnings Per Share (EPS TTM) of Palvella Therapeutics Inc (PVLA) is -4.17.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.